Senior insider sale
SVP Commercial at REGENERON PHARMACEUTICALS, INC. — senior position signals high conviction
$2.00M
2.35K shares
What this filing means
MCCOURT MARION plans to sell 2.35K shares of REGENERON PHARMACEUTICALS, INC. valued at approximately $2.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0001969223-26-000991
Officer· SVP Commercial
Since Dec 2018
2.35K
Shares to sell
$2.00M
Approx. market value
1.13K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RSA Vesting
N/A
12/12/2023
1.13KTotal acquired1.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2023 | RSA Vesting N/A | 1.13K | — |
| Total | 1.13K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.22K
Market value
$1.03M
9/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.13K
Market value
$969.3K
9/3/2026
Total
Units
2.35K
Value
$2.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 1.22K | $1.03M | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 1.13K | $969.3K | NASDAQ | Planned |
| Total | 2.35K | $2.00M | ||